We have previously shown that a single application of the growth factors ciliary neurotrophic factor (CNTF) or fibroblast growth factor 2 (FGF-2) to the crushed optic nerve of the frog, Rana pipiens, increases the numbers and elongation rate of regenerating retinal ganglion cell axons. Here we investigate the effects of these factors on the numbers and types of macrophages that invade the regeneration zone. In control PBS-treated nerves, many macrophages are present 100 μm distal to the crush site at 1 week after injury; their numbers halve by 2 weeks. A single application of CNTF at the time of injury triples the numbers of macrophages at 1 week, with this increase compared to control being maintained at 2 weeks. Application of FGF-2 is equally effective at 1 week, but the macrophage numbers have fallen to control levels at 2 weeks. Immunostaining with a pan-macrophage marker, ED1, and a marker for M2-like macrophages, Arg-1, showed that the proportion of the putative M2 phenotype remained at approximately 80% with all treatments. Electron microscopy of the macrophages at 1 week shows strong phagocytic activity with all treatments, with many vacuoles containing axon fragments and membrane debris. At 2 weeks with PBS or FGF-2 treatment the remaining macrophages are less phagocytically active, containing mainly lipid inclusions. With CNTF treatment, at 2 weeks many of the more numerous macrophages are still phagocytosing axonal debris, although they also contain lipid inclusions. We conclude that the increase in macrophage influx seen after growth factor application is beneficial for the regenerating axons, probably due to more extensive removal of degenerating distal axons, but also perhaps to secretion of growth-promoting substances.
We have previously shown that a single application of the growth factors ciliary neurotrophic factor (CNTF) or fibroblast growth factor 2 (FGF-2) to the crushed optic nerve of the frog, Rana pipiens, increases the numbers and elongation rate of regenerating retinal ganglion cell axons. Here we investigate the effects of these factors on the numbers and types of macrophages that invade the regeneration zone. In control PBS-treated nerves, many macrophages are present 100 μm distal to the crush site at 1 week after injury; their numbers halve by 2 weeks. A single application of CNTF at the time of injury triples the numbers of macrophages at 1 week, with this increase compared to control being maintained at 2 weeks. Application of FGF-2 is equally effective at 1 week, but the macrophage numbers have fallen to control levels at 2 weeks. Immunostaining with a pan-macrophage marker, ED1, and a marker for M2-like macrophages, Arg-1, showed that the proportion of the putative M2 phenotype remained at approximately 80% with all treatments. Electron microscopy of the macrophages at 1 week shows strong phagocytic activity with all treatments, with many vacuoles containing axon fragments and membrane debris. At 2 weeks with PBS or FGF-2 treatment the remaining macrophages are less phagocytically active, containing mainly lipid inclusions. With CNTF treatment, at 2 weeks many of the more numerous macrophages are still phagocytosing axonal debris, although they also contain lipid inclusions. We conclude that the increase in macrophage influx seen after growth factor application is beneficial for the regenerating axons, probably due to more extensive removal of degenerating distal axons, but also perhaps to secretion of growth-promoting substances.
Retinal ganglion cells (RGCs) react to injury in different ways in different groups
of animals–for example, mammalian neurons mostly die and the remainder show poor
regrowth due to an inhibitory environment [1-4], fish CNS neurons survive and regenerate
successfully [5,6], while amphibian neurons
show intermediate survival rates and successful regrowth [7]. RGC death after injury was first thought to
be due to interruption of the supply of target-derived neurotrophic factors [1,8-10]. However, addition of these factors has
only partial and transient success in saving mammalian RGCs [11,12], although it is highly effective in the
frog [13]. More recent work
has shown that injury-evoked mammalian RGC death can be largely prevented by
inhibition of the leucine zipper kinase pathway [14], by preventing the formation of neurotoxic
reactive astrocytes [15], and
by eliminating retinal Zn2+ accumulation [16].In recent years, it has been proposed that macrophages play a key role in modulating
the progression of neurodegenerative diseases [17-20] and also the response to CNS injury [21-23]. Macrophages originate from
bone-marrow-derived monocytes, which circulate in the bloodstream [24] and are then capable of
infiltrating injured tissues, where they differentiate into macrophages [25,26]. Along with already-resident microglia,
these cells phagocytose debris [27] and secrete chemicals that enhance or inhibit the inflammatory
response [28,29]. Macrophage infiltration
into the eye after lens injury promotes retinal ganglion cell (RGC) survival and
regeneration [30-33]. In the peripheral nervous
system also there is strong evidence that the entry of myeloid cells is important
for axonal regeneration [27],
with their entry being dependent upon the response of the macrophage CCR2 receptor
to the cytokine CCL2 [34-36]. However,
the potential roles of phagocytic cells in modulating neuronal survival and axonal
regrowth after injury remain somewhat ambiguous, in part because of their dual pro-
and anti-inflammatory phenotypes [34,37,38].Our previous work has concentrated on RGC survival after damage to the optic nerve of
the frog, Rana pipiens, and the beneficial effects of topical
growth factor administration upon that survival [13,39-42]. Recently we showed that the speed of RGC
axonal regeneration is also increased by a single application of ciliary
neurotrophic factor (CNTF) or fibroblast growth factor 2 (FGF-2) [43]. In the course of that
study we found large numbers of cells with the ultrastructural characteristics of
macrophages that congregated at the injury site, confirming an observation made by
our laboratory two decades earlier [44]. From these results, and from previous studies implicating
CNTF-induced macrophages in regeneration [33], the question arose as to whether the
application of the growth factors could increase the numbers of macrophages present,
and it is this question that we address in the present study. The results of these
experiments show that application of these growth factors, in particular CNTF, does
increase and prolong the numbers of macrophages in the nerve.
Materials and methods
Animals
Adult frogs (Rana pipiens) of both sexes were used. They were
obtained from Connecticut Valley Biological Supply Company (Southampton, MA) and
kept in tanks with recirculating tap water at 19°C. A total of approximately 50
animals were used for the immunohistochemistry and electron microscopy
experiments. This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health, and the recommendations of the Panel on
Euthanasia of the American Veterinary Medical Association. The protocol was
approved by the Institutional Animal Care and Use Committee of the University of
Puerto Rico Medical Sciences Campus. All surgery was performed under tricaine
anesthesia, and all efforts were made to minimize suffering.
Surgical technique for optic nerve crush
With animals under 0.3% tricaine anesthesia, the right eyeball was approached
from the palate in which an incision was made; the extraocular muscles were
teased aside, and the extracranial portion of the optic nerve was exposed.
Avoiding large blood vessels, the nerve was crushed at the halfway point using
Dumont No. 5 forceps. This leaves the meningeal sheath intact but creates a
transparent gap that is completely free of axons. We have confirmed the lack of
even the smallest of axons in this region by electron microscopic observation;
also, crushing in this manner perturbs RGC survival almost as effectively as
cutting [13]. The
incision was sutured, and the animals were allowed to recover for several hours
in the laboratory under observation before replacing them in their tanks in the
animal facility.
Neurotrophic factor application
Immediately after the optic nerve was crushed, it was placed on a strip of
Parafilm and 5 μl of FGF-2 or CNTF solution was applied directly to the crush
lesion. The solution was left in place for 5 min, then the Parafilm was removed
and the palate sutured. Control applications consisted of 5 μl of
phosphate-buffered saline (PBS: 0.1M). For FGF-2 (R & D Systems, MN, USA)
and CNTF (Sigma, St Louis, MO, USA) 125 ng total were applied, dissolved in 5 μl
of 0.1M PBS, pH 7.4.
Resin embedding for light and electron microscopy
Animals were euthanized one and two weeks after optic nerve crush and PBS, CNTF,
or FGF-2 application (N = 3–6 per treatment). With animals under 1% tricaine +
0.04% NaHCO3 anesthesia, the head of the animal was cut off and the
region of the optic nerve was approached from the palate and left in fixative
overnight (2% paraformaldehyde + 2% glutaraldehyde in diluted in 0.1 M
cacodylate buffer with 0.05% CaCl2). The next day, the samples were
washed twice in 0.1 M cacodylate buffer, 5 minutes each. The proximal and distal
stumps of the optic nerve and a portion of the eyeball were carefully dissected
then postfixed under a fume hood with 1% osmium tetroxide (OsO4)
diluted in cacodylate buffer for 1 h. Subsequently, the samples were dehydrated
in 25%, 50%, and 70% ethanol, 5 minutes each, then were placed in 3% uranyl
acetate diluted in 70% ethanol for 1 h. The dehydration process was continued,
placing the nerves in 90% ethanol (5 minutes), three times in 100% ethanol (20
minutes each), and 10 minutes in propylene oxide. The nerves were infiltrated
with 50/50 Epon-Araldite resin and propylene oxide for 1 h, then in 100%
Epon-Araldite and left in the desiccator overnight. The next day the nerve
samples were placed in cubic molds and embedded in 100% resin, then placed in a
60°C oven for 24 hours. The resin block was trimmed and, using an ultramicrotome
(Sorvall MT-2), transverse sections were cut; semi-thin sections (1 μm thick)
for light microscopy, and ultrathin (90 nm) for electron microscopy. For light
microscopy, semi-thin sections were stained using methylene blue-azure II and
basic fuschin. Thin sections were examined with a JEOL JEM-1011 electron
microscope equipped with a Gatan digital camera (Model-832) to describe the
ultrastructural features of the nerve.
Light microscopy cell counts
Serial 1 μm resin sections were cut from the optic nerve, starting at the distal
stump and working proximally until the injury site was reached, collecting the
sections every 50 μm. The section 100 μm distal to the injury site was used for
detailed analysis, because many regenerating axons have reached this point at
one week [43]. In
addition, preliminary cell counts indicated that cells were present at all
levels in the nerve, from the crush site to 700 um distal to it, and that the
100 um distance is fairly representative of the cell numbers overall (S1 Table).
Composite high magnification light microscope images of the nerve were examined
in Adobe Photoshop or GIMP. Image filenames were first coded so as to blind the
observer to whether they came from experimental or control animals. Color
overlays were constructed by a trained observer (JMB), outlining the nerve and
macrophage-like cell bodies within it. Macrophage cell profiles were identified
by their large size, dark cytoplasm, and the presence of granules and/or
cytoplasmic vacuoles. It is possible that some of the smallest profiles
identified by these criteria may represent phagocytic microglia that are
intrinsic to the nerve rather than peripherally-derived macrophages. The
overlays were thresholded in ImageJ (Fiji) and cell numbers and sizes were
quantified automatically using the Analyze Particles function.
Immunohistochemistry
After dissection, 3–5 eye cups with optic nerves attached were fixed for each
control and experimental stage with buffered 2% paraformaldehyde solution for 1
hr. After PBS washing, the tissues were placed in 30% sucrose for cryoprotection
at 4°C overnight, and, after being frozen, cryostat sections of 12–20 μm were
cut. After air-drying, sections were immersed in 10 mM citrate buffer (pH 6) for
10 min at 60°C. The sections were washed twice (5 min each) in PBS containing
0.3% Triton X-100 + 0.5% bovine serum albumin (BSA) and incubated for 30 minutes
in the same buffer containing 10% normal goat serum (NGS; for, ED1) or 10%
normal rabbit serum (NRS; for Arg1). They were then incubated with the
antibodies against ED1 (1:100; catalog # MCA5709; ABD Serotec) and Arginase 1
(1:100; catalog # sc-18355; Santa Cruz Biotechnology), diluted in 0.1M PBS +
0.3% Triton X-100 + 0.5% BSA, overnight at 4°C. After several washes in the same
buffer solution the sections were incubated with goat anti-mouse Cy2 (1:100,
Jackson ImmunoResearch Laboratories, Inc.), rabbit anti-goat CY3 (1:100, Jackson
ImmunoResearch Laboratories, Inc) for 2 h at room temperature. For ED1 and Arg1
sections, we labeled the cell nuclei with 4',6-diamidino-2-phenylindole (DAPI)
staining for 5 minutes after the secondary antibodies. The sections were rinsed
in 0.1 M PBS six times, 5 minutes each, and mounted in Polymount.Omitting the primary antibodies resulted in the absence of immunostaining. The
ED1 antibody recognizes rodent and bovineCD68 or macrosialin, which has some
homology with amphibian lysosomal proteins. Additionally, a second polyclonal
antibody against CD-68 (Abcam #ab124212) gave a very similar staining pattern.
The Arg1 polyclonal antibody recognizes the C terminus of mammalianarginase 1,
the likely antigenic regions of which show almost 70% identity with amphibian
arginase. Because we cannot be completely sure that the antibodies indeed
recognize frog homologs of these mammalian proteins, we refer to the staining as
“ED1-like immunoreactivity” (ED1-LI) and “Arg1-like immunoreactivity”
(Arg1-LI).Frozen sections of the whole optic nerve processed with ED1 and Arg1 were used to
count the macrophages at the injury site. Alternating longitudinal sections
through the nerve were analyzed to avoid overlap of data. The number of stained
macrophages of each type was counted from confocal images obtained with a Zeiss
Pascal laser scanning confocal microscope, using Zeiss LSM5 Image Browser
Software, then expressed as a proportion (Arg1/ED1). The statistical
significance was determined using ANOVA with post-hoc
Tukey-Kramer tests (*P < 0.05, **P < 0.01, ***P < 0.001).
Electron microscopic analysis of phagocytic structures
Sub-cellular structures (“organelles”) indicative of phagocytic activity were
quantified from electron micrographs of macrophage cell profiles. These
organelles were classified as (1) phagocytic vacuoles, which ranged from 1 to 6
μm in diameter and were electron lucent and contained obvious cellular debris;
(2) multilamellar bodies, which ranged from 0.5 to 3 μm in diameter and were
composed of multiple electron-dense lamellae or vesicles; and (3) lipid
droplets, which ranged from 0.3 to 2 μm in diameter, were generally
homogeneously electron-lucent and had no bounding membrane. Organelles of these
types were counted and their areas measured using Fiji in 230 cells from 3
animals per experimental group. The total area of each type of structure per
cell was expressed as a percentage of the total area of all the organelles, thus
standardizing for variations caused by different cell profile sizes, oblique
sections, and partial image cropping. Data were plotted as kernel density
(“violin”) plots with superimposed box-whisker plots showing the median and
25–75 percent quartiles (box) and minimum/maximum values (whiskers). Since data
were not normally distributed the statistical significance was determined using
ANOVA with post-hoc Mann-Whitney pairwise comparisons using
Bonferroni corrected p-values (*P < 0.05, **P < 0.01, ***P <
0.001).
Results
Growth factor application increases the numbers of macrophages in the injured
optic nerve
Transverse 1 μm resin sections of control optic nerves were examined with light
microscopy (Fig 1). We chose
to focus on the region 100 μm distal to the crush site because many regenerating
axons have reached this point at one week [43]. Macrophages were identified by their
large size, dark staining and granular/vacuolar appearance (Fig 1A and 1C. In PBS-treated controls, from
71 to105 macrophage cell profiles were counted in this region from overlays
(Fig 1B, N = 6 animals).
Because the cross-sectional area of the nerve varied somewhat between
preparations (0.089–0.225 mm2), this count was converted to cell
density, giving a mean of 644 ± 38 cells/mm2 (N = 6, Fig 1D). Treatment with CNTF
increased macrophage cell density 2.7-fold to 1751 ± 481 cells/mm2 at
1 w (N = 3, Fig 1E).
Treatment with FGF-2 was equally effective, increasing cell density 2.5-fold to
1591 ± 309 cells/mm2 at 1 w (N = 3, Fig 1E).
(A and C) Light micrographs of 1 μm resin sections of optic nerves, taken
100 μm distal to the crush zone. A is a PBS-treated control, C is from a
CNTF-treated animal. The insets show enlarged examples of macrophage
cell profiles, showing dark staining, granules, and vacuoles. (B and D)
Color overlays of the light micrographs, delineating macrophage cell
profiles (red) and the nerve itself (yellow). The cell count and nerve
area derived from these overlays are shown below. (E and F). Combined
scatterplots and barcharts of cell density showing mean ± SEM. Asterisks
or “ns” above each column indicate the significance when compared to PBS
(row 1, gray) or CNTF (row 2, red) with ANOVA and
post-hoc Tukey tests. (E) At 1 w after nerve crush
there are increases in cell density with CNTF and FGF-2 treatment,
compared to PBS-treated controls. (F) 2 weeks after crush, only CNTF
treatment shows an effect.
(A and C) Light micrographs of 1 μm resin sections of optic nerves, taken
100 μm distal to the crush zone. A is a PBS-treated control, C is from a
CNTF-treated animal. The insets show enlarged examples of macrophage
cell profiles, showing dark staining, granules, and vacuoles. (B and D)
Color overlays of the light micrographs, delineating macrophage cell
profiles (red) and the nerve itself (yellow). The cell count and nerve
area derived from these overlays are shown below. (E and F). Combined
scatterplots and barcharts of cell density showing mean ± SEM. Asterisks
or “ns” above each column indicate the significance when compared to PBS
(row 1, gray) or CNTF (row 2, red) with ANOVA and
post-hoc Tukey tests. (E) At 1 w after nerve crush
there are increases in cell density with CNTF and FGF-2 treatment,
compared to PBS-treated controls. (F) 2 weeks after crush, only CNTF
treatment shows an effect.By two weeks after axotomy the numbers of macrophages in the region 100 μm distal
to the crush site was significantly decreased by about half in control
PBS-treated animals, to 294 ± 93 cells/mm2 (N = 3, p = 0.017,
homoscedastic t-test). The cell density remained elevated 3-fold with CNTF
treatment at 887 ± 323 cells/mm2 (N = 4, Fig 1F), although this was significantly less
than at 1 w (p = 0.035, homoscedastic t-test). However, cell density with FGF-2
treatment had fallen to control levels (342 ± 271 cells/mm2, N = 4,
Fig 1F).The macrophage overlays allowed the quantification of various parameters of the
cell profiles. We were interested to determine whether the cells became larger
as a result of growth factor treatment, and so measured their diameter (Feret
diameter, ie. longest diameter of each profile). Diameters were segregated in 10
μm bins for each preparation, then these totals were expressed as a percentage
of the total number of cells and averaged over the experimental animals (Fig 2). The majority (90%) of
the cell profiles fell in the range of 20–40 μm (Fig 2). However, we found no significant
changes in cell size as a result of growth factor treatment (ANOVA followed by
post-hoc Tukey tests), and neither were there any changes
in size between 1 week (Fig
2A) and 2 weeks after optic nerve injury (Fig 2B).
Fig 2
Growth factor treatment does not alter macrophage size.
(A and B). Histograms of cell profile diameter (Feret diameter) averaged
over several preparations, showing mean ± SEM for each size category.
There are no significant differences in cell sizes with growth factor
treatment, either at one or two weeks, and no changes in the population
of profile diameters between those times.
Growth factor treatment does not alter macrophage size.
(A and B). Histograms of cell profile diameter (Feret diameter) averaged
over several preparations, showing mean ± SEM for each size category.
There are no significant differences in cell sizes with growth factor
treatment, either at one or two weeks, and no changes in the population
of profile diameters between those times.
Growth factor application does not alter the relative proportions of
macrophage types
Macrophages in mammals can be divided into two broad types: pro-inflammatory M1
and alternatively-activated pro-repair M2, which can be distinguished by their
expression of different antigenic markers. During spinal cord injury the
pro-inflammatory type overwhelms the small, transient, M2 response [22,28]. We were therefore interested to
determine whether frog macrophages could be identified as M1 or M2 and to find
out whether their relative proportions changed at different times after injury
and growth factor treatment.Longitudinal frozen sections of optic nerves were stained with two antibodies,
ED1 and Arg1 (Fig 3).
Counterstaining with DAPI showed that most, but not all, cells within the
control, PBS-treated optic nerves were ED1-positive (Fig 3A–3D). The ED1 antibody recognizes the
mammalianCD68 (macrosialin in mouse) protein, which is expressed in the
lysosomes of all macrophages [45-47]. BLAST
searches indicated some homology with amphibian lysosomal proteins so it is
possible that ED1 also labels a Rana homolog of CD68. In any
case, it is clear from high magnification images (Fig 3A and 3B) that ED1 does indeed stain
lysosome-like structures, confirming its utility as a pan-macrophage marker in
amphibia.
Fig 3
Immunostaining of macrophage subtypes.
(A—D) Confocal fluorescence micrographs of immunostained frozen sections
of optic nerve 1 week after axotomy. (B) High magnification single slice
of a macrophage with an irregular nucleus, clearly showing
ED1-LI-stained lysosomes. (C) Double staining of peripherally-located
macrophages with ED1 and Arg1. Only a few cells have predominantly
ED1-LI with little Arg1-LI (asterisks). (D) Double staining of
centrally-located macrophages with ED1 and Arg1. Only a few cells have
predominantly ED1-LI (asterisks). (E and F). Combined scatterplots and
barcharts of Arg1-LI/ED1-LI ratio showing mean ± SEM. Asterisks or “ns”
above each column indicate the significance when compared to PBS (row 1,
gray) or CNTF (row 2, red) with ANOVA and post-hoc
Tukey tests. At 1 w (E) and 2 w (F) after nerve crush there is no change
in the Arg1-LI/ED1-LI proportion with CNTF and FGF-2 treatment, compared
to PBS-treated controls. Scale bar: 20 μm in A, C, D; 10 μm in B.
Immunostaining of macrophage subtypes.
(A—D) Confocal fluorescence micrographs of immunostained frozen sections
of optic nerve 1 week after axotomy. (B) High magnification single slice
of a macrophage with an irregular nucleus, clearly showing
ED1-LI-stained lysosomes. (C) Double staining of peripherally-located
macrophages with ED1 and Arg1. Only a few cells have predominantly
ED1-LI with little Arg1-LI (asterisks). (D) Double staining of
centrally-located macrophages with ED1 and Arg1. Only a few cells have
predominantly ED1-LI (asterisks). (E and F). Combined scatterplots and
barcharts of Arg1-LI/ED1-LI ratio showing mean ± SEM. Asterisks or “ns”
above each column indicate the significance when compared to PBS (row 1,
gray) or CNTF (row 2, red) with ANOVA and post-hoc
Tukey tests. At 1 w (E) and 2 w (F) after nerve crush there is no change
in the Arg1-LI/ED1-LI proportion with CNTF and FGF-2 treatment, compared
to PBS-treated controls. Scale bar: 20 μm in A, C, D; 10 μm in B.The Arg1 antibody recognizes the C terminus of mammalianarginase 1, which is a
classical marker for pro-repair M2 macrophages [48]. A BLAST search of the likely antigenic
regions of this molecule showed an almost 70% identity with amphibian arginase,
making it likely that Arg1 stains arginase, and therefore M2-like macrophages,
in Rana. We carried out double immunostaining of optic nerve
sections using Arg1-like immunoreactivity (Arg1-LI) along with ED1-like
immunoreactivity (ED1-LI) to determine how the relative proportion of putative
M2 macrophages changed after injury and growth factor treatment (Fig 3). In fact, we found that
at 1 week after injury the proportion of Arg1-LI/ED1-LI macrophages was
approximately 80% (Fig 3E),
and that it remained at this level at 2 weeks after injury (Fig 3F). Treatment with CNTF or FGF-2 had no
effect on the relative proportions of Arg1-LI/ED1-LI macrophages, even though
the total numbers were increased (see Fig 1). This result indicates that in
Rana, unlike rodents, there is a high proportion of
putative M2 (pro-repair) macrophages present soon after injury, and that this
proportion remains unchanged for at least 2 weeks, during the period when
regeneration is taking place [43].
Ultrastructural characteristics of macrophages in the optic nerve after
injury
The optic nerve is surrounded by the meningeal sheath, a connective tissue layer
that protects the CNS and separates it from the environment. Beneath this is the
glia limitans, a layer made up of astrocytes, glial cells
that characteristically exhibit large bundles of intermediate filaments and
desmosomes [44]. One week
after optic nerve crush, actively phagocytosing macrophages were present inside
the optic nerve, presumably playing a role in clearance of the debris (Fig 4). Cells with large
vacuoles were common, particularly in central regions of the nerve (Fig 4D). These vacuoles
appeared to contain the remnants of degenerating axons and myelin. Other cells
contain fewer large vacuoles and more multilamellar and multivesicular bodies
(Fig 4E). Two weeks
after nerve crush, there appeared to be fewer macrophages in the nerve (Fig 4F and 4G). Those which
were present, both peripherally and centrally, contained fewer vacuoles with
axonal debris and more, less-electron-dense, homogeneously-stained inclusions
which likely represent lipid droplets, since they had no bounding membrane and
sometimes showed signs of coalescence (Fig 4F inset).
Fig 4
Electron microscopy of macrophages in PBS controls.
(A) Low power electron micrograph of the optic nerve periphery at 1 w
after injury, with a pale yellow overlay indicating the nerve and pale
red overlay indicating numerous macrophages within it. (B) Peripheral
macrophages containing a variety of multilamellar and multivesicular
bodies, products of phagocytic activity. (C) Macrophage with an
irregular nucleus (n) and large debris-filled multilamellar bodies. (D)
Centrally located macrophages containing large vacuoles with apparent
remnants of degenerating axons. (E) Central, smaller (possibly
microglia) cell with multilamellar and multivesicular bodies. (F)
Peripheral macrophages at 2 weeks, located within the glia limitans
(gl). Some vacuoles with axonal debris are present but the cytoplasm
also contains lipid inclusions (asterisks) and dark granules (g). Inset:
high magnification view of putative lipid inclusions, showing lack of a
bounding membrane. (G) Large central macrophage with a bilobed nucleus
(n) at 2 weeks, containing a mixture of vacuoles with axonal debris, and
lipid inclusions (asterisks). Scale bar: 20 μm in A; 5 μm in B, D; 2 μm
in C, E, F, G; 0.5 μm in inset.
Electron microscopy of macrophages in PBS controls.
(A) Low power electron micrograph of the optic nerve periphery at 1 w
after injury, with a pale yellow overlay indicating the nerve and pale
red overlay indicating numerous macrophages within it. (B) Peripheral
macrophages containing a variety of multilamellar and multivesicular
bodies, products of phagocytic activity. (C) Macrophage with an
irregular nucleus (n) and large debris-filled multilamellar bodies. (D)
Centrally located macrophages containing large vacuoles with apparent
remnants of degenerating axons. (E) Central, smaller (possibly
microglia) cell with multilamellar and multivesicular bodies. (F)
Peripheral macrophages at 2 weeks, located within the glia limitans
(gl). Some vacuoles with axonal debris are present but the cytoplasm
also contains lipid inclusions (asterisks) and dark granules (g). Inset:
high magnification view of putative lipid inclusions, showing lack of a
bounding membrane. (G) Large central macrophage with a bilobed nucleus
(n) at 2 weeks, containing a mixture of vacuoles with axonal debris, and
lipid inclusions (asterisks). Scale bar: 20 μm in A; 5 μm in B, D; 2 μm
in C, E, F, G; 0.5 μm in inset.
One week after optic nerve injury and treatment with CNTF, large numbers of
macrophages were found within the optic nerve, both peripherally (Fig 5A and 5B) and centrally
(Fig 5C and 5D). These
appeared to be highly active phagocytically, judging by the large numbers and
sizes of debris-containing vacuoles and multilamellar bodies. Additionally,
other cell types, such as the smaller microglia and neutrophils (Fig 5C) were also occasionally
observed. Compared to PBS controls, there was the appearance of more macrophages
with large vacuoles at the periphery of the nerve (Fig 5A and 5B).
Fig 5
Electron microscopy of macrophages in 1 w CNTF-treated nerve.
(A) Low power electron micrograph of the optic nerve periphery, showing
numerous macrophages containing large debris-filled vacuoles. Also
present are smaller microglia (m) and neurotrophil-like cells (n). (B)
Active macrophages, with many large vacuoles, at nerve periphery. (C)
Central macrophage with multiple phagocytic vacuoles, multilamellar
bodies and also lipid inclusions (asterisk). Next to it is a
neutrophil-like cell (n). (D) Centrally located macrophages with
numerous multilamellar and multivesicular bodies. Scale bar: 10 μm in A;
5 μm in B, C, D.
Electron microscopy of macrophages in 1 w CNTF-treated nerve.
(A) Low power electron micrograph of the optic nerve periphery, showing
numerous macrophages containing large debris-filled vacuoles. Also
present are smaller microglia (m) and neurotrophil-like cells (n). (B)
Active macrophages, with many large vacuoles, at nerve periphery. (C)
Central macrophage with multiple phagocytic vacuoles, multilamellar
bodies and also lipid inclusions (asterisk). Next to it is a
neutrophil-like cell (n). (D) Centrally located macrophages with
numerous multilamellar and multivesicular bodies. Scale bar: 10 μm in A;
5 μm in B, C, D.Two weeks after optic nerve injury and CNTF treatment, large numbers of cells
were still present within the optic nerve, both peripherally (Fig 6A–6C) and centrally
(Fig 6D–6F). Some were
very large (Fig 6D) and
probably were indeed macrophages, while others were smaller in size (Fig 6E) and may represent
microglia. Compared to PBS controls at this stage, the more numerous cells in
CNTF-treated nerves still showed signs of ongoing phagocytosis, containing
vacuoles with axonal debris and multilamellar myelin/membrane remnants, as well
as the numerous lipid inclusions seen at 2 w in PBS controls. Some of these
cells also contained small dark membrane-bound structures that resemble
secretory granules (Fig 6A and
6D).
Fig 6
Electron microscopy of macrophages in 2 w CNTF-treated nerve.
(A) Low power electron micrograph of the optic nerve periphery, showing
macrophages containing some multilamellar bodies, also lipid inclusions
(asterisks) and small dark granules (g). (B) Peripheral microglia-like
cell containing multilamellar bodies and lipid inclusions (asterisk).
(C) Peripheral unknown cell type containing rough endoplasmic reticulum
and lipid inclusions (asterisk). (D) Large, centrally located macrophage
with multilamellar bodies, vacuoles containing axonal debris, and lipid
inclusions (asterisks). Around its nucleus are numerous dark granules
(g). (E) Central macrophage/microglia with multilamellar bodies, in
close proximity to many small axons (a). (F) Macrophage with
multilamellar bodies and lipid inclusions, in proximity to axons (a).
Scale bar: 5 μm in A, D; 2 μm in B, C, E, F.
Electron microscopy of macrophages in 2 w CNTF-treated nerve.
(A) Low power electron micrograph of the optic nerve periphery, showing
macrophages containing some multilamellar bodies, also lipid inclusions
(asterisks) and small dark granules (g). (B) Peripheral microglia-like
cell containing multilamellar bodies and lipid inclusions (asterisk).
(C) Peripheral unknown cell type containing rough endoplasmic reticulum
and lipid inclusions (asterisk). (D) Large, centrally located macrophage
with multilamellar bodies, vacuoles containing axonal debris, and lipid
inclusions (asterisks). Around its nucleus are numerous dark granules
(g). (E) Central macrophage/microglia with multilamellar bodies, in
close proximity to many small axons (a). (F) Macrophage with
multilamellar bodies and lipid inclusions, in proximity to axons (a).
Scale bar: 5 μm in A, D; 2 μm in B, C, E, F.
Effects of FGF-2 treatment on macrophage ultrastructure
One week after optic nerve injury and treatment with FGF-2, as with CNTF, large
numbers of active macrophages were observed in the optic nerve (Fig 7A and 7B). These
contained vacuoles with axonal debris and multivesicular/multilamellar bodies.
Other types of blood cells, such as eosinophils, were occasionally found (Fig 7A). At two weeks after
FGF-2 treatment, fewer macrophages were present in the optic nerve, similar to
controls. Those that were found were large, contained numerous lipid inclusions
(see above) (Fig 7C–7E), and
some had multilamellar bodies and dark (possibly secretory) granules (Fig 7D).
Fig 7
Electron microscopy of macrophages in FGF-2-treated nerve.
(A) Peripheral macrophages at 1w, containing multilamellar bodies. Also
present is a possible granulocyte, with a bilobed nucleus and dark
granules (e). (B) Macrophages in the central optic nerve at 1w,
containing vacuoles with axonal debris. (C) Peripheral nerve at two
weeks showing macrophage with lipid inclusions (asterisk). (D) Large,
centrally located macrophage at 2 w with multilamellar bodies, axonal
debris and lipid inclusions (asterisks). Around its nucleus are numerous
dark granules (g). (E) A similar large central macrophage with a highly
indented nucleus and lipid inclusions (asterisk). Scale bar: 2 μm.
Electron microscopy of macrophages in FGF-2-treated nerve.
(A) Peripheral macrophages at 1w, containing multilamellar bodies. Also
present is a possible granulocyte, with a bilobed nucleus and dark
granules (e). (B) Macrophages in the central optic nerve at 1w,
containing vacuoles with axonal debris. (C) Peripheral nerve at two
weeks showing macrophage with lipid inclusions (asterisk). (D) Large,
centrally located macrophage at 2 w with multilamellar bodies, axonal
debris and lipid inclusions (asterisks). Around its nucleus are numerous
dark granules (g). (E) A similar large central macrophage with a highly
indented nucleus and lipid inclusions (asterisk). Scale bar: 2 μm.
Quantitative analysis of phagocytic organelle distributions
In order to confirm the preceding qualitative impressions of the amount of
phagocytic activity, we carried out a quantitative analysis of the relative
areas occupied by phagocytic vacuoles, multilamellar/multivesicular bodies and
lipid inclusions, in 230 cells from 3 experimental animals per group. The total
area of each type of organelle per cell was expressed as a percentage of the
total area of all the organelles, thus standardizing for variations caused by
different cell profile sizes, oblique sections, and partial image cropping.
Rather than carry out a multivariate analysis, the phagocytic vacuoles and
multilamellar bodies were initially grouped together as “phagocytic organelles”,
so as to compare them with the distribution of lipid inclusions (Fig 8A).
Fig 8
CNTF treatment prolongs phagocytic activity.
Kernel density (“violin”) plots with superimposed box-whisker plots of
organelle areas, expressed as a percentage of the total organelle area.
Asterisks or “ns” above each column indicate the significance when
compared to PBS (rows 1 and 4, gray), CNTF (rows 2 and 5, red), or FGF2
(row 3, blue) with ANOVA and post-hoc Mann-Whitney
comparisons using Bonferroni p-correction (*P < 0.05, **P < 0.01,
***P < 0.001). (A) Comparison of relative areas occupied by
“phagocytic organelles” (vacuoles + multilamellar bodies) versus lipid
inclusions. At one week, the majority of cells are predominantly
occupied by “phagocytic organelles” as opposed to lipid inclusions. At
two weeks most cells are occupied predominantly by lipid inclusions in
PBS controls, but there is a significant increase in phagocytic cells
with CNTF treatment. N (cells) = 42, 42, 36, 24, 41, 43. (B) Comparison
of relative areas occupied by multilamellar bodies versus phagocytic
vacuoles (combined as “phagocytic organelles” in Fig 8A). At one week
after FGF2 treatment, there is a significant increase in the median area
occupied by multilamellar bodies. At two weeks most cells are occupied
by multilamellar bodies, although smaller populations remain with
phagocytic vacuoles. N (cells) = 42, 42, 36, 19, 39, 34.
CNTF treatment prolongs phagocytic activity.
Kernel density (“violin”) plots with superimposed box-whisker plots of
organelle areas, expressed as a percentage of the total organelle area.
Asterisks or “ns” above each column indicate the significance when
compared to PBS (rows 1 and 4, gray), CNTF (rows 2 and 5, red), or FGF2
(row 3, blue) with ANOVA and post-hoc Mann-Whitney
comparisons using Bonferroni p-correction (*P < 0.05, **P < 0.01,
***P < 0.001). (A) Comparison of relative areas occupied by
“phagocytic organelles” (vacuoles + multilamellar bodies) versus lipid
inclusions. At one week, the majority of cells are predominantly
occupied by “phagocytic organelles” as opposed to lipid inclusions. At
two weeks most cells are occupied predominantly by lipid inclusions in
PBS controls, but there is a significant increase in phagocytic cells
with CNTF treatment. N (cells) = 42, 42, 36, 24, 41, 43. (B) Comparison
of relative areas occupied by multilamellar bodies versus phagocytic
vacuoles (combined as “phagocytic organelles” in Fig 8A). At one week
after FGF2 treatment, there is a significant increase in the median area
occupied by multilamellar bodies. At two weeks most cells are occupied
by multilamellar bodies, although smaller populations remain with
phagocytic vacuoles. N (cells) = 42, 42, 36, 19, 39, 34.This analysis showed that at 1 week after axotomy, in all three conditions, the
great majority of macrophage-like cells contain predominantly “phagocytic
organelles” rather than lipid inclusions. At two weeks, on the other hand, PBS
controls showed a mixture of cell types, with a large population containing few
“phagocytic organelles” and predominantly lipid inclusions, and a smaller
population containing more evidence of ongoing phagocytosis. The kernel density
(“violin”) plots indicate the presence of two cell populations with a division
at about 50% phagocytic:50% lipid area. Applying this cutoff, 79% of the cells
analyzed contained predominantly lipid inclusions, versus 21% with phagocytic
organelles. FGF2-treated animals at 2 weeks showed no significant difference in
the median phagocytic area although the population spread appeared wider (Fig 8A). CNTF treatment,
however, showed a significant increase in the population of cells that had more
area occupied by phagocytic organelles than lipid inclusions. Applying the 50:50
cutoff between populations indicated that 61% of cells fall in this category
(Fig 8A). This result
supports our qualitative observations (see above) that there is more evidence of
ongoing phagocytosis persisting at two weeks in CNTF-treated animals.We then analyzed the relative distribution of the two “phagocytic organelle”
types that were previously grouped together; namely, the large debris-containing
vacuoles, which presumably indicate the relatively recent occurrence of
phagocytosis, and the multilamellar or multivesicular bodies, which probably
represent a later stage of debris processing (Fig 8B). At one week after axotomy, CNTF
treatment showed no significant difference from PBS controls, with most cells
having a larger area occupied by phagocytic vacuoles than by multilamellar
bodies. Again applying the somewhat arbitrary 50:50 cutoff between the
populations gave 80% of cells that are predominantly vacuolar in PBS animals,
and 67% in CNTF animals. However, FGF-2 treatment significantly increases the
proportion of cells that have more multilamellar bodies (Fig 8B), thus only 24% have more than 50%
phagocytic vacuoles. If multilamellar bodies represent a more advanced stage of
phagocytotic processing, this result implies that FGF2 treatment may accelerate
this process.By two weeks, the great majority of cells exhibited a preponderance of
multilamellar bodies over phagocytic vacuoles, although there persisted a
smaller cell population that had more of the latter (Fig 8B). The respective >50% vacuolar cell
counts were: PBS 32%, CNTF 44%, and FGF2 24%. There were however no significant
differences between the medians of the organelle distributions between PBS, CNTF
or FGF2 treatments.
Discussion
Early work from this laboratory and others noted the appearance of macrophages in the
axotomized optic nerve of the frog Rana pipiens [44,49]. However, this present study is the first
detailed characterization of those macrophages, investigating the timing of their
appearance after axotomy and their heterogeneity of their subpopulations. In
addition, here we also investigate how the growth factors CNTF and FGF-2, which we
have shown to affect the speed and the number of regenerating axons [43], also affect the macrophage
populations during optic nerve regeneration.Light microscope counts of macrophage-like cell profiles showed the appearance of
many cells in the regenerating region by 1 week after injury, the numbers of which
subsequently declined by half at 2 weeks. This result is consistent with our earlier
qualitative report [44], in
which the nerve was cut and the stumps separated. Macrophages in other animals show
similar large yet transient influxes after nerve injury, for example rat sciatic
nerve [50], axolotl spinal
cord and peripheral axons [51], and the optic nerves of rat, goldfish and Xenopus
tadpoles [52-54].In the absence of specific microglial markers we cannot be absolutely sure that the
smallest cell profiles identified in the light microscope are not intrinsic
microglia rather than peripherally-derived macrophages. However, mammalian microglia
have a maximal soma diameter of about 16 μm, with most being about 8 μm [55]. In our electron microscope
images we can occasionally tentatively identify microglia from their smaller (<10
μm) size (eg. Figs 4E and 5A). However, our light microscope
counts did not include cells with a Feret diameter of less than 10 μm, and the 10–20
μm category makes up only a small number of the total population (Fig 2). We are therefore confident
that the majority of cells in our analysis represent macrophages.We found that application of CNTF to the lesion doubled the number of macrophages in
the nerve without affecting their size distribution, and that this effect persisted
for 2 weeks after injury, long after the CNTF itself would had disappeared. There
are few studies which have investigated the possibility of such a chemoattractive
effect in vivo, although it has been shown that the survival- and
regeneration-enhancing effects of CNTF on rat RGCs depend upon the recruitment of
blood-derived macrophages, and that the factor indeed has a chemotactic effect on
them in vitro [33,56]. We also
found that FGF-2 application increased the number of macrophages in the nerve, but
the effect was temporary, and had disappeared by 2 weeks after injury. There are no
comparable studies of FGF-2 on macrophages in other systems, however it has been
shown that it increases the migration and survival of tumor-associated macrophages
[57]. On the contrary,
however, there appears to be increased macrophage activity after sciatic nerve
injury in FGF-2-knockout mice [58].In our previous study we investigated the effect of a single application of growth
factor to the injury site on regenerating axons at 2 weeks after injury [43]. We showed that axon speed
was increased 138% by CNTF and 63% by FGF-2, while axon numbers were increased 72%
by FGF-2 and 52% by CNTF [43]. These prolonged effects must have far outlasted the immediate actions
of the factors themselves and presumably resulted from longer-term changes in the
axonal microenvironment. In the present study we investigate one such change, i.e.
the increase in macrophages, and show that both CNTF and FGF-2 greatly increase the
numbers of these cells, but only at 1 week after injury. The timing of these events
suggests a causative effect—increased numbers of macrophages results in an
enhancement of axonal growth. However, we need to test this hypothesis by inhibition
of macrophages, and this will be the focus of a future study.By what means do the macrophages enhance axonal regrowth? One obvious answer from our
electron microscope observations is that they phagocytose the distal stumps of
severed axons, thus removing a physical impediment to axonal elongation, which
otherwise could remain in place for up to 3 months after axotomy [59]. Another possibility is
that phagocytosis removes an inhibitory chemical barrier in the myelin, as in the
mammalian CNS [60]. However,
Xenopus optic tract myelin is not inhibitory to axonal
extension (unlike that from the spinal cord)[61], despite both expressing an ortholog of
Nogo [62]. It is more likely
that, as in fish [5,63,64], the relatively few frog oligodendrocytes
and their myelin are not inhibitory.At 1 week after injury, irrespective of growth factor treatment, most macrophages
were observed to have large vacuoles containing what appeared to be axon fragments,
and multilamellar bodies that may represent myelin debris. By 2 weeks, in PBS- and
FGF-2-treated preparations the remaining macrophages tended to contain what appeared
to be lipid inclusions (not bounded by a membrane). Similar lipid inclusions, which
probably represent the end points of myelin and membrane destruction, are seen in
Xenopus astrocytes during the extensive myelin remodeling that
takes place during metamorphosis [65]. More significantly, they are also the hallmark of the so-called
“foamy” macrophages seen in the injured mouse spinal cord after the accumulation of
excessive myelin debris [66].
These PBS- and FGF-2-treated macrophages may therefore be in the final stages of
phagocytosis, while in CNTF-treated nerves the more numerous macrophages still
showed signs of ongoing phagocytosis, in addition to the lipid inclusions. This
apparent extension of the active phagocytic period, along with the overall higher
numbers of macrophages, appears to be beneficial to axonal extension. Another
possibility is that the cells themselves secrete growth-promoting substances, as is
the case with mouse M2 macrophages [28], which have increased expression of, for example, insulin-like
growth factor 1 and 2 and hepatocyte growth factor [67].Early studies gave rise to ambiguous conclusions regarding the beneficial or harmful
effects of macrophages on CNS repair after injury. However, in 2009 it was
demonstrated that the entry of different macrophage subsets into the injured rat
spinal cord, either “classically activated” proinflammatory (M1) or “alternatively
activated” anti-inflammatory (M2) [68], had different effects, the former being neurotoxic while the latter
promoted regeneration [28].
The predominance of the M1 type over the M2 was postulated to be one of the factors
responsible for poor CNS regenerative capabilities [22,28]. Macrophage polarization into M1/M2-like
phenotypes, although undoubtedly a somewhat oversimplified classification [69], appears to be conserved
throughout the vertebrates [70]. One of the distinguishing traits of the M2-like phenotype is the
expression of arginase, which is purported to have healing functions [71]. Using double
immunostaining of a putative pan-macrophage marker (ED1) along with an antibody
against arginase (Arg1), we found that the majority (80%) of macrophages that
entered the crushed frog optic nerve were Arg1+, and therefore presumably of the M2
phenotype.Application of CNTF or FGF-2 greatly increased the overall macrophage numbers without
altering the proportion of M2-like cells. Since we have shown previously that both
CNTF and FGF-2 increase the numbers and speed of axons that are regenerating through
the frog nerve [43] it is
clear that the increased presence of M2-type macrophages is entirely consistent with
them having a beneficial effect on axonal regrowth, similar to that proposed in rat
[28].Phagocytosis is, by definition, the morphological hallmark of the macrophage;
however, it is not clear from the literature whether macrophage polarization is
related to phagocytic activity. M1 macrophages in wounds have been described as
highly phagocytic, in contrast to the M2 phenotype which accelerate wound closure
[72]. On the other hand,
in recent in vitro assays, it was shown that macrophages activated
by IL-4 or IL-10 (equivalent to M2) showed higher levels of phagocytic activity
compared to those activated by IFN- ((equivalent to M1) [73,74]. Our electron microscope results clearly
show intense phagocytic activity in all of the macrophages that we examined,
particularly at 1 week after axotomy, with or without growth factor treatment. Since
we estimate that 80% of frog macrophages are Arg1-positive, and thus correspond to
the M2 subtype, our results support the idea that M2 macrophages in
vivo are phagocytically active, and that this activity is beneficial
for axonal regrowth.Our current work shows that the macrophage population in the frog optic nerve is more
diverse than previously thought. This system, in which the optic nerve can
regenerate, provides a good model to further study the roles of these populations in
modulating axonal regeneration and ganglion cell survival.
Authors: Yiqing Li; Lukas Andereggen; Kenya Yuki; Kumiko Omura; Yuqin Yin; Hui-Ya Gilbert; Burcu Erdogan; Maria S Asdourian; Christine Shrock; Silmara de Lima; Ulf-Peter Apfel; Yehong Zhuo; Michal Hershfinkel; Stephen J Lippard; Paul A Rosenberg; Larry Benowitz Journal: Proc Natl Acad Sci U S A Date: 2017-01-03 Impact factor: 11.205
Authors: Kristina A Kigerl; John C Gensel; Daniel P Ankeny; Jessica K Alexander; Dustin J Donnelly; Phillip G Popovich Journal: J Neurosci Date: 2009-10-28 Impact factor: 6.167
Authors: Wilson Ríos-Muñoz; Ileana Soto; Mildred V Duprey-Díaz; Jonathan Blagburn; Rosa E Blanco Journal: J Neurochem Date: 2005-06 Impact factor: 5.372
Authors: Ling-Ping Cen; Jian-Min Luo; Cheng-Wu Zhang; You-Ming Fan; Yue Song; Kwok-Fai So; Nico van Rooijen; Chi Pui Pang; Dennis S C Lam; Qi Cui Journal: Invest Ophthalmol Vis Sci Date: 2007-09 Impact factor: 4.799
Authors: Yuqin Yin; Silmara De Lima; Hui-Ya Gilbert; Nicholas J Hanovice; Sheri L Peterson; Rheanna M Sand; Elena G Sergeeva; Kimberly A Wong; Lili Xie; Larry I Benowitz Journal: Restor Neurol Neurosci Date: 2019 Impact factor: 2.406
Authors: Larisa Kavetsky; Kayla K Green; Bridget R Boyle; Fawad A K Yousufzai; Zachary M Padron; Sierra E Melli; Victoria L Kuhnel; Harriet M Jackson; Rosa E Blanco; Gareth R Howell; Ileana Soto Journal: Sci Rep Date: 2019-10-11 Impact factor: 4.379